Synergistic Benzathine Analog Systems

The inventive concept integrates benzathine analogs with distinct technologies such as AI, IoT, blockchain, and nanomaterials to create a new, more powerful system for treating inflammatory disorders.

The original patent disclosed methods for inhibiting pro-inflammatory cytokine release using benzathine analogs. However, these methods have limitations in terms of predicting and monitoring treatment efficacy, ensuring secure and transparent administration, and targeting specific immune cells. The new inventive concept addresses these limitations by combining benzathine analogs with advanced technologies to create a more comprehensive and effective treatment system.

The inventive concept comprises a benzathine analog integrated with one or more of the following: a machine learning algorithm for predicting pro-inflammatory cytokine release, an IoT-based sensor system for monitoring treatment response, a blockchain-based platform for secure and transparent administration, or a nanomaterial-based delivery system for targeted immune cell response. The machine learning algorithm is trained on patient data to predict treatment outcomes, and the IoT-based sensor system provides real-time monitoring of treatment response. The blockchain-based platform ensures secure and transparent administration of the benzathine analogs, and the nanomaterial-based delivery system targets specific immune cells for more effective treatment.

The new claims introduce novel combinations of benzathine analogs with advanced technologies, providing a non-obvious solution to the limitations of the original patent. The integration of machine learning, IoT, blockchain, and nanomaterials with benzathine analogs creates a new and more powerful system for treating inflammatory disorders.

Alternative embodiments of the inventive concept could include integrating benzathine analogs with other AI-based algorithms, such as natural language processing or computer vision, or using different types of nanomaterials or IoT-based sensor systems. Variations could include using different benzathine analogs or targeting different immune cells or inflammatory disorders.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the treatment of inflammatory disorders such as sepsis, pneumonia, and asthma. The integration of advanced technologies with benzathine analogs could lead to more effective and targeted treatments, improving patient outcomes and reducing healthcare costs.